Target-based Classification of Drugs

[ Brite menu | Download htext ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

     Remark
 G Protein-coupled receptors
 
 Cytokine receptors
 
 Nuclear receptors
 
 Ion channels
 
 Transporters
 
 Enzymes
 
 Protein kinases
 
 Cytokines
   Class I cytokines
   Class II cytokines
   PDGF family
   TNF family
     TNF-alpha [HSA:7124] [KO:K03156]
       Lenalidomide [DG:DG00744]
       Adalimumab
       Afelimomab
       Certolizumab pegol
       Etanercept
       Golimumab
       Infliximab
         D02598  Infliximab (genetical recombination) (JAN); Infliximab (USAN/INN)
Monoclonal antibody
       Lenercept
       Nerelimomab
       Onercept
       Ozoralizumab
       Pegsunercept
       Placulumab
     LTA [HSA:4049] [KO:K05468]
     LTB [HSA:4050] [KO:K03157]
     Lymphotoxin [HSA:4049 4050] [KO:K05468 K03157]
     TNFSF4 (OX40L) [HSA:7292] [KO:K05469]
     CD40L (CD154) [HSA:959] [KO:K03161]
     CD70 [HSA:970] [KO:K05470]
     RANKL [HSA:8600] [KO:K05473]
     APRIL [HSA:8741] [KO:K05475]
     BAFF [HSA:10673] [KO:K05476]
   IL-1 family
   IL-17 family
   TGF-beta family
   Chemokines
 
 Others

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: October 20, 2014

» Japanese version